Arix Bioscience non-executive director Sir John Banham is retiring from the board.
The company said: 'Sir John, who is 76, has been chairman of the audit and risk committee, and has helped to oversee the company's growth both as a private company and since its successful IPO on the London Stock Exchange in February.'
It said that as previously announced, Giles Kerr, who joined the board on 17 October, would takeover as chairman of the audit and risk committee. Arix Bioscience chairman Jonathan Peacock said: 'It has been a pleasure and a privilege to work with Sir John.
'On behalf of the board, I would like to thank him for his many contributions to the successful creation and early development of Arix Bioscience.'
At 9:11am: (LON:ARIX) Arix Bioscience Plc share price was 0p at 181.5p